The landscape of kinase fusions in cancer

Nicolas Stransky, Ethan Cerami, Stefanie Schalm, Joseph L. Kim, Christoph Lengauer

Research output: Contribution to journalArticle

Abstract

Human cancer genomes harbour a variety of alterations leading to the deregulation of key pathways in tumour cells. The genomic characterization of tumours has uncovered numerous genes recurrently mutated, deleted or amplified, but gene fusions have not been characterized as extensively. Here we develop heuristics for reliably detecting gene fusion events in RNA-seq data and apply them to nearly 7,000 samples from The Cancer Genome Atlas. We thereby are able to discover several novel and recurrent fusions involving kinases. These findings have immediate clinical implications and expand the therapeutic options for cancer patients, as approved or exploratory drugs exist for many of these kinases.

Original languageEnglish (US)
Article number4846
JournalNature Communications
Volume5
DOIs
StatePublished - Sep 10 2014
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Chemistry(all)
  • Physics and Astronomy(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'The landscape of kinase fusions in cancer'. Together they form a unique fingerprint.

  • Cite this

    Stransky, N., Cerami, E., Schalm, S., Kim, J. L., & Lengauer, C. (2014). The landscape of kinase fusions in cancer. Nature Communications, 5, [4846]. https://doi.org/10.1038/ncomms5846